India  

AstraZeneca jab benefits ‘outweigh risks’ but under-30s offered alternative

Video Credit: PA - Press Association STUDIO - Duration: 01:13s - Published
AstraZeneca jab benefits ‘outweigh risks’ but under-30s offered alternative

AstraZeneca jab benefits ‘outweigh risks’ but under-30s offered alternative

The benefits of the AstraZeneca vaccine outweigh the risks for the “vast majority” of people after cases of blood clots were detected in an “extremely small” number of people, Dr June Raine, chief executive of the Medicines and Healthcare products Regulatory Agency said.


You Might Like


💡 newsR Knowledge: Other News Mentions

Related news from verified sources

EU agency says AstraZeneca clot risk 'very rare'

The EU's medicines regulator said on Wednesday that blood clots should be listed as a rare side...
IndiaTimes - Published

Mexican president Andres Manuel Lopez Obrador now says he'll get AstraZeneca vaccine

Mexico's president said on Thursday he now plans to get the AstraZeneca coronavirus vaccine to boost...
IndiaTimes - Published


Related videos from verified sources

Should I be worried about the AstraZeneca Covid-19 vaccine? [Video]

Should I be worried about the AstraZeneca Covid-19 vaccine?

The UK medicines regulator has said benefits of the Oxford/AstraZeneca vaccine continue to outweigh any risks, but added that under-30s will be offered an alternative jab. Here, we take a look at the..

Credit: PA - Press Association STUDIO     Duration: 01:40Published
EMA: Benefits of AstraZeneca jab outweigh risks [Video]

EMA: Benefits of AstraZeneca jab outweigh risks

Emer Cooke, executive director of the EMA, says its review “confirmed that the benefits of the AstraZeneca vaccine in preventing Covid-19 overall outweigh the risk of side effects”.Ms Cooke added:..

Credit: PA - Press Association STUDIO     Duration: 01:35Published
UK regulator says AstraZeneca vaccine safe despite 7 clot deaths [Video]

UK regulator says AstraZeneca vaccine safe despite 7 clot deaths

UK medicines agency confirms seven deaths from rare blood clots from 18m people who received the AstraZeneca vaccine but says benefits still far outweigh risks.

Credit: Euronews English     Duration: 01:00Published